Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
MB.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
MB.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
MB.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MB.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.2.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.3.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.3.2.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.3.2.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.3.2.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.3.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.50EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.50ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.50ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.50EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.50EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.3.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.2.3.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.2.3.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.2.3.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.2.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LQ.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LQ.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LQ.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LQ.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LQ.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LQ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LQ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LY.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LY.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LY.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LY.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LY.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used